Title : Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers.

Pub. Date : 2016 May

PMID : 27113739






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers. Cyclophosphamide BRCA1 DNA repair associated Homo sapiens